Comprehensive Cancer RNA Panel Sequencing Service

CAT.NOUNITPRICE
IT300101 Sample
$0.00

Specifications


DescriptionComprehensive RNA Cancer Panel Sequencing Service provides highly multiplexed target selection of genes implicated in cancer research. Specifically, over 600 genes in the Wellcome Trust Sanger Institute Cancer Gene Census are included. This is the most comprehensive cancer RNA panel sequencing service available to date.
  • Discover common and rare genetic mutations including point mutations and low-frequency aberrations
  • Extensive multiplexing flexibility enables a more cost-effective assay
  • Ultra-deep sequencing of targeted regions to detects rare mutations
  • Comprehensive bioinformatics options for robust downstream analysis
  • Fast turnaround time
  • Paired-end sequence data from the most cutting-edge sequencing platforms
  • Dedicated, on-going support from experienced abm scientists
SKUIT30010
Applications
  • Cancer biomarker discovery
  • Cancer mechanism study
  • Cancer therapeutic target discovery
  • Design genetic tests, such as for pharmacogenomics or oncology
  • Somatic mutation detection
SpeciesHuman (H. sapiens)
Unit quantity1 Sample
Documents


Supporting Protocol

    MSDS

      QC

        Other

          FAQs


          There are no FAQs for this product yet!
          References


          There are no references for this product yet!